Literature DB >> 18403330

Fibrogenesis of parenchymal organs.

Tatiana Kisseleva1, David A Brenner.   

Abstract

Fibrosis of parenchymal organs is caused by prolonged injury, deregulation of the normal processes of wound healing, and extensive deposition of extracellular matrix (ECM) proteins. The current review will focus on common features of fibrogenesis in parenchymal organs, and will briefly discuss common features and differences in the pathophysiology of fibrosis. Comparison of hepatic, renal, and pulmonary fibrosis has identified several common mechanisms. Common themes include a critical role for the cytokine transforming growth factor beta and the generation of reactive oxygen species. Activated myofibroblasts are the common cell type that produce the excessive fibrous scar and may originate from endogenous cells such as hepatic stellate cells or fibroblasts, from the bone marrow such as fibrocytes, or from the transition of epithelial cells to mesenchymal cells. These concepts open new prospects for multidisciplinary research and the development of new therapies for fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403330      PMCID: PMC2645245          DOI: 10.1513/pats.200711-168DR

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  48 in total

1.  Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels.

Authors:  S M Huber; G S Braun; S Segerer; R W Veh; M F Horster
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

Review 2.  Renal interstitial fibrosis: remembrance of things past?

Authors:  Doris Herzlinger
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 3.  Mechanisms of fibrogenesis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2008-02

Review 4.  TGF-beta signaling and the fibrotic response.

Authors:  Andrew Leask; David J Abraham
Journal:  FASEB J       Date:  2004-05       Impact factor: 5.191

Review 5.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

Review 6.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 7.  New insights into TGF-beta-Smad signalling.

Authors:  Peter ten Dijke; Caroline S Hill
Journal:  Trends Biochem Sci       Date:  2004-05       Impact factor: 13.807

Review 8.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

9.  Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis.

Authors:  Albert J Czaja; Herschel A Carpenter
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

10.  Angiogenesis induction and regression in human surgical wounds.

Authors:  Nicola J Brown; Edward A E Smyth; Simon S Cross; Malcolm W R Reed
Journal:  Wound Repair Regen       Date:  2002 Jul-Aug       Impact factor: 3.617

View more
  73 in total

Review 1.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

2.  Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection.

Authors:  Tatiana Kisseleva; Maren von Köckritz-Blickwede; Donna Reichart; Shauna M McGillvray; Gerhard Wingender; Mitchell Kronenberg; Christopher K Glass; Victor Nizet; David A Brenner
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

3.  Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity.

Authors:  Kazuyuki Tsujino; Yoshito Takeda; Toru Arai; Yasushi Shintani; Ryosaku Inagaki; Hiroyuki Saiga; Takeo Iwasaki; Satoshi Tetsumoto; Yingji Jin; Shoichi Ihara; Toshiyuki Minami; Mayumi Suzuki; Izumi Nagatomo; Koji Inoue; Hiroshi Kida; Takashi Kijima; Mari Ito; Masanori Kitaichi; Yoshikazu Inoue; Isao Tachibana; Kiyoshi Takeda; Meinoshin Okumura; Martin E Hemler; Atsushi Kumanogoh
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

Review 4.  Fibroblasts in three dimensional matrices: cell migration and matrix remodeling.

Authors:  Sangmyung Rhee
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

Review 5.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

6.  Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro.

Authors:  Amanda B Muir; Diana M Lim; Alain J Benitez; Prasanna Modayur Chandramouleeswaran; Anna J Lee; Eduardo D Ruchelli; Jonathan M Spergel; Mei-Lun Wang
Journal:  Exp Cell Res       Date:  2012-12-10       Impact factor: 3.905

Review 7.  Management of Cirrhotic Patients After Successful HCV Eradication.

Authors:  Ryan M Kwok; Tram T Tran
Journal:  Curr Treat Options Gastroenterol       Date:  2017-06

8.  Renal fibrosis.

Authors:  G Efstratiadis; M Divani; E Katsioulis; G Vergoulas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

9.  Intrahepatic biliary ablation with pure ethanol: an experimental model of biliary atresia.

Authors:  Yukihiro Tatekawa; Akira Nakada; Tatsuo Nakamura
Journal:  Surg Today       Date:  2012-10-17       Impact factor: 2.549

Review 10.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.